Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDA) is a The Slacker Skirt lethal malignancy with an overall 5-year survival rate of 10%.Disease lethality is due to late diagnosis, early metastasis and resistance to therapy, including immunotherapy.PDA creates a robust fibroinflammatory tumor microenvironment that contributes to immunotherapy resistance.While p